Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

2.
3.

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Pavelić K, Krizanac S, Cacev T, Hadzija MP, Radosević S, Crnić I, Levanat S, Kapitanović S.

Mol Med. 2001 Jul;7(7):442-53.

4.
5.

Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.

Cao J, Li W, Xie J, Du H, Tang W, Wang H, Chen X, Xiao W, Li Y.

Surg Oncol. 2006 Dec;15(4):223-33. Epub 2007 Mar 26.

PMID:
17382535
6.

Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.

Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K, McCue PA.

Cancer. 2000 Jan 1;88(1):24-34.

PMID:
10618602
7.

Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma.

Li H, Zhao P, Lu Y, Lu Y.

Int J Colorectal Dis. 2012 Aug;27(8):1015-20. Epub 2012 Feb 9.

PMID:
22315171
8.

Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.

Wierzbicki PM, Adrych K, Kartanowicz D, Dobrowolski S, Stanislawowski M, Chybicki J, Godlewski J, Korybalski B, Smoczynski M, Kmiec Z.

J Physiol Pharmacol. 2009 Oct;60 Suppl 4:63-70.

9.

Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.

Cao J, Chen XP, Li WL, Xia J, Du H, Tang WB, Wang H, Chen XW, Xiao HQ, Li YY.

World J Gastroenterol. 2007 Feb 21;13(7):1018-26.

10.
11.

Involvement of galectin-3 expression in colorectal cancer progression and metastasis.

Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Nakajima A, Hida JI, Miyake M, Shindo K, Yasutomi M.

Int J Oncol. 1999 Jul;15(1):143-8.

PMID:
10375607
13.

Loss of fragile histidine triad expression in colorectal carcinoma.

Zhao P, Lu Y, Hu Y, Zhong M, Li Z, Li X.

Zhonghua Bing Li Xue Za Zhi. 2002 Apr;31(2):124-7.

PMID:
12419158
14.
15.

Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.

Luceri C, Guglielmi F, De Filippo C, Caderni G, Mini E, Biggeri A, Napoli C, Tonelli F, Cianchi F, Dolara P.

Scand J Gastroenterol. 2000 Jun;35(6):637-41.

PMID:
10912665
16.

Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.

Yu HG, Shun LB, Luo HS, Huang H, Yu BP, Yu JP, Meier JJ, Schrader H, Bastian A, Schmitz F, Schmidt WE.

Int J Colorectal Dis. 2002 Nov;17(6):396-401. Epub 2002 May 29.

PMID:
12355215
17.

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, Mori M.

Cancer Res. 2006 Mar 1;66(5):2683-90.

18.
19.

Down-regulation of fragile histidine triad expression in prostate carcinoma.

Fouts RL, Sandusky GE, Zhang S, Eckert GJ, Koch MO, Ulbright TM, Eble JN, Cheng L.

Cancer. 2003 Mar 15;97(6):1447-52.

20.

Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.

Kitamura A, Yashima K, Okamoto E, Andachi H, Hosoda A, Kishimoto Y, Shiota G, Ito H, Kaibara N, Kawasaki H.

Oncology. 2001;61(3):205-11.

PMID:
11574776
Items per page

Supplemental Content

Write to the Help Desk